A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Summary

The goal of this clinical trial is to evaluate the efficacy and safety of Gecacitinib in combination with pegylated interferon for the treatment of polycythemia vera (PV).The main question it aims to answer is: Can PV patients achieve hematological remission after receiving the combination therapy? Participants will: Receive combination treatment with Gecacitinib Hydrochloride Tablets and pegylated interferon for 24 weeks Visit the hospital regularly for examinations and follow-up assessments

Timeline

Start

2026-04-02

Primary completion

2026-12-30

Completion

2028-12-30

Drugs

Indications